We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIOD icon
1751
Diodes
DIOD
$4.84B
$208K ﹤0.01%
3,234
+2,853
+749% +$208K
GBDC icon
1752
Golub Capital BDC
GBDC
$3.42B
$208K ﹤0.01%
16,048
+15,075
+1,549% +$216K
TRMK icon
1753
Trustmark
TRMK
$2.75B
$208K ﹤0.01%
7,116
+5,911
+491% +$171K
EYE icon
1754
National Vision
EYE
$1.81B
$207K ﹤0.01%
7,517
+5,539
+280% +$183K
INSP icon
1755
Inspire Medical Systems
INSP
$1.74B
$206K ﹤0.01%
1,130
-824
-42% -$164K
WLDN icon
1756
Willdan Group
WLDN
$1.3B
$206K ﹤0.01%
7,439
+7,301
+5,291% +$200K
XES icon
1757
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$364M
$206K ﹤0.01%
3,452
-792
-19% -$57.1K
NUVA
1758
DELISTED
NuVasive, Inc.
NUVA
$206K ﹤0.01%
4,197
-1,507
-26% -$80.8K
SPDW icon
1759
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.7B
$205K ﹤0.01%
7,112
-705
-9% -$22.3K
WBT
1760
DELISTED
Welbilt, Inc.
WBT
$205K ﹤0.01%
8,604
+7,965
+1,246% +$188K
GSK icon
1761
GSK
GSK
$106B
$204K ﹤0.01%
3,758
+3,756
+187,800% +$207K
TAL icon
1762
TAL Education Group
TAL
$6.87B
$204K ﹤0.01%
41,898
+25,369
+153% +$96.9K
CROX icon
1763
Crocs
CROX
$6.55B
$203K ﹤0.01%
4,161
-356
-8% -$21.6K
AMBA icon
1764
Ambarella
AMBA
$3.81B
$202K ﹤0.01%
3,088
+2,280
+282% +$184K
CASH icon
1765
Pathward Financial
CASH
$1.8B
$202K ﹤0.01%
5,212
+4,689
+897% +$200K
DHC
1766
Diversified Healthcare Trust
DHC
$2.14B
$202K ﹤0.01%
110,971
+106,966
+2,671% +$244K
KOMP icon
1767
State Street SPDR S&P Kensho New Economies Composite ETF
KOMP
$2.81B
$202K ﹤0.01%
4,986
+4,253
+580% +$191K
MPLX icon
1768
MPLX
MPLX
$59.7B
$202K ﹤0.01%
6,928
-5,235
-43% -$168K
OFIX icon
1769
Orthofix Medical
OFIX
$419M
$201K ﹤0.01%
8,558
+1,857
+28% +$53.2K
PMVP icon
1770
PMV Pharmaceuticals
PMVP
$63.5M
$201K ﹤0.01%
14,102
+13,017
+1,200% +$189K
TMP icon
1771
Tompkins Financial
TMP
$1.42B
$201K ﹤0.01%
2,792
-2,740
-50% -$203K
CUTR
1772
DELISTED
Cutera, Inc.
CUTR
$201K ﹤0.01%
5,375
+5,058
+1,596% +$267K
GDXJ icon
1773
VanEck Junior Gold Miners ETF
GDXJ
$8.46B
$200K ﹤0.01%
6,228
+1,994
+47% +$82.2K
IPO icon
1774
Renaissance IPO ETF
IPO
$161M
$200K ﹤0.01%
6,644
-6,790
-51% -$229K
ADT icon
1775
ADT
ADT
$5.58B
$199K ﹤0.01%
32,419
+29,295
+938% +$204K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.